Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents-Reference-Cited by-同舟云学术

Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents

Published:2015-12-17 Issue:1 Volume:59 Page:90-113
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Greene Thomas F.¹,Wang Shu¹,Greene Lisa M.²,Nathwani Seema M.²,Pollock Jade K.²,Malebari Azizah M.¹,McCabe Thomas³,Twamley Brendan³,O’Boyle Niamh M.¹²,Zisterer Daniela M.²,Meegan Mary J.¹

Affiliation:

1. School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland

2. School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearse Street, Dublin 2, Ireland

3. School of Chemistry, Trinity College Dublin, Dublin 2, Ireland

Funder

Enterprise Ireland

Science Foundation Ireland

Irish Research Council

Trinity College Dublin

Health Research Board

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b01086

Reference55 articles.

1. Combretastatins: More Than Just Vascular Targeting Agents?

2. EU/3/04/195;European Medicines Agency:London, 2004; http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000545.jsp&mid=WC0b01ac058001d12b(accessed 13 May 2015) .

3. Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

4. Anthony, S. P.; Read, W.; Rosen, P. J.; Tibes, R.; Park, D.; Everton, D.; Tseng, B.; Whisnant, J.; Von Hoff, D. D.Initial results of a first-in-man phase I study of EPC2407, a novel small molecule microtubule inhibitor anticancer agent with tumor vascular endothelial disrupting activity. InJournal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings (Post-Meeting Edition);Vol 26, No 15S (May 20 Supplement), 2008, 2531.

5. A new synthesis of combretastatins A-4 and AVE-8062A

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent;European Journal of Medicinal Chemistry;2024-03

2. N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations;Chinese Chemical Letters;2024-02

3. 3,4-Diarylisoxazoles─Analogues of Combretastatin A-4: Design, Synthesis, and Biological Evaluation In Vitro and In Vivo;ACS Pharmacology & Translational Science;2024-01-16

4. Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers;Bioorganic Chemistry;2023-12

5. Antiproliferative and Tubulin-Destabilising Effects of 3-(Prop-1-en-2-yl)azetidin-2-Ones and Related Compounds in MCF-7 and MDA-MB-231 Breast Cancer Cells;Pharmaceuticals;2023-07-13